VanHimbergen Robert M 4

What Happened

• Robert M. VanHimbergen, Executive Vice President and Chief Financial Officer of Elanco Animal Health (ELAN), was granted 8.216 deferred stock units (DSUs) on 2026-03-20. The grant is recorded at $23.98 per unit for a total reported value of $197. This was an award/grant (derivative), not an open-market purchase or sale.

Key Details

• Transaction date: 2026-03-20; Form 4 filed: 2026-03-24 (filed within the typical two-business-day window).
• Transaction type/code: A — Award/Grant (derivative instrument: deferred stock units).
• Quantity and valuation: 8.216 DSUs @ $23.98 each = $197 total.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes: F1 — Each DSU represents the right to one share of common stock or the cash equivalent. F2 — DSUs settle in cash or shares following termination of employment or in a specified future year under the Executive Deferral and Stock Match Plan.

Context

• This was a compensation award (deferred units) rather than a purchase or sale; DSUs are a form of deferred pay and do not represent immediate share ownership or an immediate market signal. Payout will occur later in cash or stock per the plan rules.